Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
2123 |
|
| Actual shortage: | 50 (2%) | |
| Anticipated shortage: | 9 (0%) | |
| Avoided shortage: | 19 (1%) | |
| Resolved: | 2045 (96%) | |
Discontinuation Reports |
101 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 98 (97%) | |
| Reversed: | 2 (2%) | |
Late reports |
444 (20%) |
|
Overdue reports |
38 (63%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP | 10MG | LIQUID | Resolved | 2022-10-26 | 2023-01-19 | 172683 |
| DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP | 10MG | LIQUID | Resolved | 2023-07-10 | 2023-08-08 | 197961 |
| DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP | 10MG | LIQUID | Resolved | 2023-05-08 | 2023-05-31 | 191996 |
| DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML | 4MG | SOLUTION | Resolved | 2023-05-30 | 2023-06-28 | 193383 |
| DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML | 4MG | SOLUTION | Resolved | 2023-02-14 | 2023-04-12 | 184624 |
| DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML | 4MG | SOLUTION | Resolved | 2017-08-02 | 2017-10-18 | 18152 |
| DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML | 4MG | SOLUTION | Resolved | 2022-12-28 | 2023-01-19 | 179482 |
| DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML | 4MG | SOLUTION | Resolved | 2021-01-12 | 2021-01-25 | 131386 |
| DIAZEPAM INJECTION USP | 10MG | SOLUTION | Resolved | 2021-01-18 | 2021-01-25 | 131820 |
| DILTIAZEM HYDROCHLORIDE INJECTION | 5MG | SOLUTION | Resolved | 2023-03-03 | 2023-04-12 | 186152 |
| DIMENHYDRINATE INJECTION USP | 50MG | SOLUTION LIQUID | Resolved | 2024-08-27 | 2024-09-04 | 236038 |
| DIMENHYDRINATE INJECTION USP | 10MG | SOLUTION LIQUID | Resolved | 2023-12-04 | 2024-01-03 | 212442 |
| DIPHENHYDRAMINE HYDROCHLORIDE INJECTION USP | 50MG | LIQUID | Resolved | 2017-03-14 | 2018-05-23 | 2541 |
| DIPHENHYDRAMINE HYDROCHLORIDE INJECTION USP | 50MG | LIQUID | Resolved | 2022-07-20 | 2022-10-20 | 165112 |
| DIPHENHYDRAMINE HYDROCHLORIDE INJECTION USP | 50MG | LIQUID | Resolved | 2023-01-19 | 2023-02-09 | 181679 |
| DIPHENHYDRAMINE HYDROCHLORIDE INJECTION USP | 50MG | LIQUID | Resolved | 2023-05-01 | 2023-09-20 | 191388 |
| DOBUTAMINE INJECTION USP | 12.5MG | LIQUID | Resolved | 2023-04-21 | 2023-07-05 | 190144 |
| DOBUTAMINE INJECTION USP | 12.5MG | LIQUID | Resolved | 2022-09-01 | 2022-10-26 | 168466 |
| DOCETAXEL INJECTION | 10MG | SOLUTION | Resolved | 2017-03-14 | 2017-05-17 | 2556 |
| DOCETAXEL INJECTION | 10MG | SOLUTION | Avoided shortage | 2024-01-08 | 2024-02-05 | 215330 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |